Iterum Therapeutics plc (ITRMF) Change in Cash (2017 - 2025)

Iterum Therapeutics' Change in Cash history runs 9 years deep, the most recent figure standing at -$2.0 million for Q3 2025.

• In Q3 2025, Change in Cash fell 124.07% year-over-year to -$2.0 million; the TTM figure through Sep 2025 stood at -$2.4 million (down 128.04% YoY), while the FY2024 annual figure was $18.1 million, up 220.19% from the prior year.
• Change in Cash for Q3 2025 stood at -$2.0 million, down from $374000.0 in the prior quarter.
• The five-year high for Change in Cash was $51.9 million in Q1 2021, with the low at -$30.1 million in Q2 2021.
• The 5-year median for Change in Cash is -$621000.0 (2021), against an average of -$199210.5.
• The sharpest annual moves came in 2022 and 2025: Change in Cash jumped 1916.43% in 2022, then slumped 970.49% in 2025.
• Iterum Therapeutics' Change in Cash stood at -$8.5 million in 2021, then soared by 106.71% to $573000.0 in 2022, then soared by 119.02% to $1.3 million in 2023, then surged by 754.1% to $10.7 million in 2024, then plunged by 118.93% to -$2.0 million in 2025.
• Business Quant data shows ITRMF's Change in Cash at -$2.0 million in Q3 2025, $374000.0 in Q2 2025, and -$11.5 million in Q1 2025.